---
title: 'Long-Term Outcomes of Testosterone Treatment in Men: A T4DM Post-Randomisation
  Observational Follow-Up Study'
date: '2023-08-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37623257/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230825181111&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: We conclude that randomized T treatment for 24 months in
  men with impaired glucose tolerance or new diabetes but without pathological hypogonadism
  was associated with higher levels of self-reported benefits and diagnosis of sleep
  apnea during, but not after, the study as well as more frequent prescribed post-study
  testosterone treatment consistent with androgen dependence in some men receiving
  prolonged injectable ...'
disable_comments: true
---
CONCLUSIONS: We conclude that randomized T treatment for 24 months in men with impaired glucose tolerance or new diabetes but without pathological hypogonadism was associated with higher levels of self-reported benefits and diagnosis of sleep apnea during, but not after, the study as well as more frequent prescribed post-study testosterone treatment consistent with androgen dependence in some men receiving prolonged injectable ...